Skip to main content
GutCited

이눌린 그림

49 동료 심사 연구의 그림

전체 생강 아연 이눌린 커큐민 락타아제 베르베린 차전자피 비피도박테리움 롱검 비피도박테리움 락티스 비피도박테리움 비피덤 사카로마이세스 보울라디 락토바실루스 가세리 락토바실루스 플란타룸 락토바실루스 애시도필루스 부티레이트(나트륨/칼슘 부티레이트) 페퍼민트 오일 바실루스 코아굴란스 췌장효소(판크렐리파아제) 알로에 베라(내엽 젤) 알파-갈락토시다아제 소 초유 오메가-3 지방산(EPA/DHA) 비타민 A 비타민 D 프럭토올리고당(FOS) 갈락토올리고당(GOS) L-글루타민 중쇄중성지방(MCT 오일) N-아세틸시스테인(NAC)
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
FIGURE 1. Consort flow diagram of patient enrollment, allocation, and analysis.
Figure 2 Flowchart

CONSORT flow diagram detailing patient enrollment, randomization, allocation to treatment and control groups, and final analysis in the IBS-C kombucha intervention trial. Dropout rates and reasons for exclusion are documented at each stage.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 2. Study design.
Figure 3 Diagram

Study design schematic illustrating the intervention protocol, including kombucha drink composition (with inulin and vitamin supplementation), dosing schedule, and assessment timepoints across the trial period.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 3. The severity of bloating in patients of the studied groups.
Figure 4 Chart

Comparison of bloating severity scores between the kombucha intervention group and control group over the study period. Reductions in bloating severity suggest the enriched kombucha drink may be associated with symptomatic improvement in IBS-C patients.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 4. The severity of the feeling of incomplete emptying in patients of the studied groups.
Figure 5 Chart

Assessment of the feeling of incomplete bowel emptying in IBS-C patients receiving the kombucha-based drink versus controls. Severity scores at multiple timepoints indicate a trend toward improvement in the intervention group.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 5. Stool frequency of the studied groups.
Figure 6 Chart

Stool frequency data comparing the kombucha intervention and control groups across the study timeline. Increased bowel movement frequency in the treatment group suggests a potential benefit of the inulin- and vitamin-enriched kombucha formulation.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

FIGURE 6. Stool consistency of the studied groups.
Figure 7 Chart

Stool consistency scores evaluated using the Bristol Stool Scale for both study groups. Improvements in stool consistency over the intervention period suggest the kombucha-based drink may help normalize bowel habits in IBS-C patients.

Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins …

Figure 6
Figure 6 Chart

Comparative analysis of individual IBS symptom domains across treatment groups, evaluating the differential effects of the inulin-choline-silymarin supplement.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

At the initial evaluation, we found that three patients (5.89%) had mild symptoms (total symptoms score < 175), 26 patients (50.98%) had moderate symptoms (total symptoms score between 175 and 300) and 22 patients (43.13%) had severe IBS symptoms (tota
Figure 7 Chart

Symptom severity distribution at the initial evaluation, revealing that approximately half of the IBS-C patients presented with moderate symptoms while over 40% had severe manifestations.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 3.Figure 3. IBS total symptoms score after 28 days.IBS total symptoms score after 28 days.
Figure 8 Chart

Total IBS symptom scores measured at the 28-day assessment point, comparing outcomes between the supplemented and control diet groups in the crossover design.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 9
Figure 9 Chart

Analysis of gastrointestinal symptom domains in the IBS-C study at an intermediate time point, tracking changes in bloating, pain, and bowel habit parameters.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 10
Figure 10 Chart

Stool frequency and consistency measurements during the treatment phase, evaluating whether inulin-based supplementation improved bowel regularity in IBS-C patients.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 11
Figure 11 Chart

Quality of life assessment data from IBS-C patients, comparing self-reported well-being between supplementation and control periods.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 12
Figure 12 Chart

Individual patient response trajectories over the treatment period, illustrating the variability in symptom improvement with the prebiotic supplement.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 13
Figure 13 Chart

Subgroup analysis of treatment response stratified by baseline symptom severity, exploring whether patients with severe IBS-C derived greater benefit from supplementation.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 14
Figure 14 Chart

Secondary endpoint analysis from the IBS-C trial, including measures of abdominal discomfort and transit time.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 7. IBS symptom scores after 56 days.
Figure 15 Chart

IBS symptom scores after 56 days of treatment, providing longer-term efficacy data for the inulin, choline, and silymarin supplementation regimen.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 16
Figure 16 Chart

Crossover period analysis comparing symptom trajectories when patients switched between the supplemented and unsupplemented diet phases.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 8. Stools number/week and stools consistency after 56 days.
Figure 17 Chart

Stool frequency per week and stool consistency measurements after 56 days, indicating sustained effects of the prebiotic supplement on bowel function.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 18
Figure 18

Summary of adverse events or tolerability data from the IBS-C supplementation trial, documenting the safety profile of the inulin-choline-silymarin combination.

Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with …

Figure 2
Figure 2

From Structure to Function: How Prebiotic Diversity Shapes Gut Integrity and Immune …

Figure 3
Figure 3

From Structure to Function: How Prebiotic Diversity Shapes Gut Integrity and Immune …

Figure 4
Figure 4

From Structure to Function: How Prebiotic Diversity Shapes Gut Integrity and Immune …

Figure 5
Figure 5

From Structure to Function: How Prebiotic Diversity Shapes Gut Integrity and Immune …

Figure 5. Established prebiotic effects for intestinal and systemic health.
Figure 6

Figure 5. Established prebiotic effects for intestinal and systemic health.

From Structure to Function: How Prebiotic Diversity Shapes Gut Integrity and Immune …

3페이지 중 2페이지